Characterizing neurocognitive impairment in young people with major depression: state, trait, or scar?

Show simple item record

dc.contributor.author Allott, Kelly
dc.contributor.author Fisher, Caroline A
dc.contributor.author Amminger, Gunther Paul
dc.contributor.author Goodall, Joanne
dc.contributor.author Hetrick, Sarah
dc.coverage.spatial United States
dc.date.accessioned 2024-01-10T00:50:50Z
dc.date.available 2024-01-10T00:50:50Z
dc.date.issued 2016-10
dc.identifier.citation (2016). Brain and Behavior, 6(10), e00527-.
dc.identifier.issn 2162-3279
dc.identifier.uri https://hdl.handle.net/2292/67152
dc.description.abstract Background: Major depressive disorder (MDD) affects a quarter of adolescents and young adults and is associated with the greatest global burden of disease in this population. There is a growing literature, mostly in adults, showing that significant neurocognitive impairments are common in MDD. It remains unclear whether these impairments are pre-existing trait markers of MDD, state-related impairments that fluctuate with depressive symptoms, or ‘scar’ impairments that worsen with illness progression. The aim of this study is to provide a conceptual framework for understanding MDD and neurocognitive impairment in adolescence and young adulthood (ages 12–25 years). Method: Examination of the evidence for neurocognitive deficits as trait, state, and scar features of MDD according to different study designs (family studies, premorbid studies, current depression, remitted depression, and longitudinal studies with repeated assessment) was conducted. Results: The few premorbid and family studies conducted in youth provide equivocal evidence for neurocognitive impairments as trait markers of MDD. The presence of state-based neurocognitive impairment remains unclear as evidence comes mostly from cross-sectional studies. There are a limited, but growing number of longitudinal studies with repeated neurocognitive assessment in youth. Studies that examined neurocognition prior to the onset of MDD and with long-term follow-up provide tentative evidence for neurocognitive scarring. Conclusion: Neurocognitive impairment is a feature of MDD in adolescents and young adults. To better understand the nature, timing, and pattern of impairment, longitudinal studies that examine neurocognition before and after the development of full-threshold MDD, including following recurrence are needed. This knowledge will have important implications for mechanisms, prevention, and treatment of MDD in youth.
dc.format.medium Electronic-eCollection
dc.language eng
dc.publisher Wiley
dc.relation.ispartofseries Brain and behavior
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.subject Humans
dc.subject Depressive Disorder, Major
dc.subject Adolescent
dc.subject Adult
dc.subject Child
dc.subject Young Adult
dc.subject Cognitive Dysfunction
dc.subject adolescence
dc.subject cognition
dc.subject deficits
dc.subject early intervention
dc.subject major depressive disorder
dc.subject neuropsychological
dc.subject young adulthood
dc.subject youth
dc.subject 32 Biomedical and Clinical Sciences
dc.subject 3202 Clinical Sciences
dc.subject 52 Psychology
dc.subject Depression
dc.subject Pediatric
dc.subject Brain Disorders
dc.subject Behavioral and Social Science
dc.subject Neurosciences
dc.subject Mental Health
dc.subject Clinical Research
dc.subject Serious Mental Illness
dc.subject 2.1 Biological and endogenous factors
dc.subject 2 Aetiology
dc.subject 3 Good Health and Well Being
dc.subject Science & Technology
dc.subject Life Sciences & Biomedicine
dc.subject Behavioral Sciences
dc.subject Neurosciences & Neurology
dc.subject COGNITIVE DEFICITS
dc.subject NEUROPSYCHOLOGICAL DEFICITS
dc.subject SCHIZOPHRENIFORM DISORDER
dc.subject ADOLESCENT DEPRESSION
dc.subject TREATMENT REMISSION
dc.subject EXECUTIVE FUNCTION
dc.subject EARLY-CHILDHOOD
dc.subject MENTAL-HEALTH
dc.subject RISK-FACTORS
dc.subject IQ SCORE
dc.subject 1103 Clinical Sciences
dc.subject 1117 Public Health and Health Services
dc.subject Clinical
dc.subject Clinical Medicine and Science
dc.subject 1109 Neurosciences
dc.subject 1701 Psychology
dc.subject 1702 Cognitive Sciences
dc.subject 3209 Neurosciences
dc.subject 5202 Biological psychology
dc.title Characterizing neurocognitive impairment in young people with major depression: state, trait, or scar?
dc.type Journal Article
dc.identifier.doi 10.1002/brb3.527
pubs.issue 10
pubs.begin-page e00527
pubs.volume 6
dc.date.updated 2023-12-28T20:58:49Z
dc.rights.holder Copyright: The authors en
dc.identifier.pmid 27781141 (pubmed)
pubs.author-url https://www.ncbi.nlm.nih.gov/pubmed/27781141
pubs.publication-status Published
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Research Support, Non-U.S. Gov't
pubs.subtype review-article
pubs.subtype Review
pubs.subtype Journal Article
pubs.elements-id 650330
pubs.org-id Medical and Health Sciences
pubs.org-id School of Medicine
pubs.org-id Psychological Medicine Dept
dc.identifier.eissn 2162-3279
dc.identifier.pii BRB3527
pubs.number ARTN e00527
pubs.record-created-at-source-date 2023-12-29
pubs.online-publication-date 2016-07-21


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics